Amprion
PrivateLast Round
Series B
Oct 9, 2024
Total Funding Raised
$16.66M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Amprion operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Grant round in September 2024.
Amprion is a biotechnology company that develops diagnostic tests to detect misfolded proteins for the early diagnosis of neurodegenerative diseases such as Parkinson's and Alzheimer's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amprion Comparables
Compare Amprion with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CND Life Sciences | 87% | |
| Sunbird Bio | 81% | |
| C2N Diagnostics | 80% |
For institutional investors. Book with your work email.
Amprion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 9, 2024 | ||||
| Grant | Sep 12, 2024 | ||||
| Grant | May 10, 2022 | ||||
| Grant | Apr 15, 2021 | ||||
| Grant | Nov 15, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Amprion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Formation Venture Engineering | Series B |
| ALS Network | Grant |
| National Institute of Neurological Disorders and Stroke | Grant |
| Alzheimer's Drug Discovery Foundation | Grant, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 80% MoM, reaching 4.8K.
- Jul 13, 2026
Open roles increased to 10, 2.1x the trailing average.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesSep 18, 2026
Amprion Inc. launches SAAmplify-αSYN Plus, a cerebrospinal fluid test designed to detect alpha-synuclein aggregates and help differentiate multiple system atrophy from Parkinson’s disease and other atypical parkinsonian disorders, and makes it available on Sep 15th '26.
- attends_eventSep 18, 2026
Amprion Inc. plans to present related research through four posters and two oral presentations and appears at booth 210 at the 2026 International Congress of Parkinson's Disease and Movement Disorders in South Korea on Oct 4th-8th '26.
- launchesSep 15, 2026
Amprion Inc. launches SAAmplify-?SYN Plus.
- partners_withAug 12, 2026
On Aug 12th '26, Amprion Inc. partners with MLM Medical Labs GmbH in a strategic licensing collaboration to enable alpha-synuclein testing for biopharma-sponsored clinical trials in Europe.
For institutional investors. Book with your work email.
Amprion Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Amprion's valuation, stock price, and market status.
Is Amprion a public or private company?
Amprion is a private company.
What is the current stock price of Amprion?
Amprion is a private company, so its shares have no public market price. Caplight tracks Amprion's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Amprion worth (valuation)?
Valuation information for Amprion is not publicly available.
Can I buy Amprion stock?
Amprion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Amprion's last funding round?
Amprion's most recent funding round was Series B on October 9, 2024.
Who are the main investors in Amprion?
Key investors in Amprion include Formation Venture Engineering.
Will Amprion IPO soon?
No public IPO plans have been announced for Amprion.
How can I track Amprion secondary market activity?
Caplight tracks bids, offers, and trades in Amprion's shares on secondary markets.